Adnan Kastrati

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

Dirk Sibbing, Julia Stegherr, Wolfgang Latz et al. · European Heart Journal · 2008 · 416 citations · Full text

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis

Stephan Windecker, Stefan Stortecky, Giulio Stefanini et al. · BMJ · 2014 · 352 citations · Full text

Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction

Werner Koch, Adnan Kastrati, Corinna Böttiger et al. · Atherosclerosis · 2001 · 182 citations

Inflammation, Epidemiology, Cardiovascular Epidemiology +15

Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting

Adnan Kastrati, Werner Koch, Peter B. Berger et al. · Journal of the American College of Cardiology · 2000 · 119 citations

Inflammation, Percutaneous Coronary Intervention, Vascular Disease +12

Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.

Adnan Kastrati, Helmut Schühlen, Jöerg Hausleiter et al. · PubMed · 1997 · 92 citations